SABS fundamentals
The current financial position of SAB Biotherapeutics, Inc.
Total assets of SABS for Q1 25 is 38.12 M USD, 17.24% less than the previous Q4 24. And total liabilities decreased by 16.83% in Q1 25 to 16.71 M USD.
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total assets
Total liabilities
Currency: USD
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25